Published in J Thorac Cardiovasc Surg on March 01, 1999
Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg (2000) 1.63
Antireflux surgery, barrett esophagus, and adenocarcinoma: there is still room for doubt. Ann Surg (2007) 1.44
Correlation of oesophageal acid exposure with Barrett's oesophagus length. Gut (2001) 1.34
Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction. World J Surg (2003) 1.23
Barrett's oesophagus: from metaplasia to dysplasia and cancer. Gut (2005) 1.18
Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery. Ann Surg (2003) 1.08
NERD, GERD, and Barrett's esophagus: role of acid and non-acid reflux revisited with combined pH-impedance monitoring. Dig Dis Sci (2008) 0.97
Natural history of Barrett's esophagus. World J Gastroenterol (2012) 0.93
Proximal and distal esophageal sensitivity is decreased in patients with Barrett's esophagus. World J Gastroenterol (2011) 0.92
Metaplastic columnar mucosa in the cervical esophagus after esophagectomy. Ann Surg (2002) 0.91
Risk factors for the progression of endoscopic Barrett's epithelium in Japan: a multivariate analysis based on the Prague C & M Criteria. Dig Dis Sci (2008) 0.89
Shape of Barrett's epithelium is associated with prevalence of erosive esophagitis. World J Gastroenterol (2010) 0.88
Recurrent Barrett's esophagus and adenocarcinoma after esophagectomy. BMC Gastroenterol (2004) 0.87
Effect of body mass index on adenocarcinoma of gastric cardia. World J Gastroenterol (2003) 0.86
Pathophysiology and treatment of Barrett's esophagus. World J Gastroenterol (2010) 0.85
Esophageal bacteria and Barrett's esophagus: a preliminary report. Dig Dis Sci (2004) 0.83
Symptoms, acid exposure and motility in patients with Barrett's esophagus. Can J Surg (2004) 0.83
Barrett's esophagus with high-grade dysplasia: focus on current treatment options. World J Gastroenterol (2011) 0.82
Higher prevalence of obesity in gastric cardia adenocarcinoma compared to gastric non-cardia adenocarcinoma. Dig Dis Sci (2012) 0.81
Fundoplication for gastroesophageal reflux and factors associated with the outcome 6 to 10 years after the operation: multivariate analysis of prognostic factors using the propensity score. Surg Endosc (2008) 0.78
Endocytoscopic visualization of squamous cell islands within Barrett's epithelium. World J Gastrointest Endosc (2013) 0.76
Oesophageal pH monitoring in Barrett's oesophagus. Gut (2003) 0.75
Ambulatory pH Monitoring: New Advances and Indications. Gastroenterol Hepatol (N Y) (2006) 0.75
Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. Curr Oncol (2006) 0.75
Mechanisms of Barrett's oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects. Best Pract Res Clin Gastroenterol (2014) 0.75
The importance of symptom assessment in the surgical treatment of gastroesophageal reflux disease and Barrett's esophagus. Surg Endosc (2006) 0.75
How should Barrett's ulceration be treated? Surg Endosc (2004) 0.75
Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg (1980) 4.60
Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg (1986) 4.22
Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res (2001) 3.70
Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg (1994) 3.09
Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol (1992) 2.96
Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg (1983) 2.91
The polymorphic acetylation of dapsone in man. Clin Pharmacol Ther (1971) 2.81
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res (2000) 2.73
A contemporaneous comparison of hospital charges for laparoscopic and open Nissen fundoplication. Surg Endosc (1995) 2.59
Evaluation of esophageal motor function in clinical practice. Neurogastroenterol Motil (2013) 2.54
Laparoscopic repair of large type III hiatal hernia: objective followup reveals high recurrence rate. J Am Coll Surg (2000) 2.53
Clinical and physiologic comparison of laparoscopic and open Nissen fundoplication. J Am Coll Surg (1995) 2.44
Induction of tumour immunity with tumour cells treated with iodoacetate. Nature (1966) 2.42
A prospective, randomized comparison of laparoscopic appendectomy with open appendectomy. Laparoscopic Appendectomy Study Group. Am J Surg (1995) 2.37
Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg (1994) 2.25
Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol (1986) 2.25
The lower esophageal sphincter in health and disease. Am J Surg (1988) 2.17
Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg (1995) 2.17
Studies on the metabolic basis for the genetically determined capacities for isoniazid inactivation in man. J Pharmacol Exp Ther (1965) 2.16
STUDIES IN DIABETIC ACIDOSIS AND COMA, WITH PARTICULAR EMPHASIS ON THE RETENTION OF ADMINISTERED POTASSIUM. J Clin Invest (1949) 2.12
Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg (1999) 2.07
Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci (1992) 2.04
Does duodenal juice reflux into the esophagus of patients with complicated GERD? Evaluation of a fiberoptic sensor for bilirubin. Am J Surg (1995) 1.98
Management of esophageal perforation. Am J Surg (1980) 1.90
Current concepts in the management of paraesophageal hiatal hernia. J Clin Gastroenterol (1999) 1.84
The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with "typical" symptoms. Ann Surg (1998) 1.81
Acute pancreatitis with hyperlipemia. Surgery (1971) 1.79
Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg (1983) 1.75
Pathogenesis of esophagitis in patients with gastroesophageal reflux. Surgery (1980) 1.74
Esophageal function in patients with angina-type chest pain and normal coronary angiograms. Ann Surg (1982) 1.71
Laparoscopic management of benign solid and cystic lesions of the liver. Ann Surg (1999) 1.70
Clinical and in vitro analysis of determinants of gastroesophageal competence. A study of the principles of antireflux surgery. Am J Surg (1979) 1.69
Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg (1994) 1.68
Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg (2001) 1.66
Surgery and the management of peripheral lung tumors adherent to the parietal pleura. J Thorac Cardiovasc Surg (1992) 1.64
Length of the distal esophageal sphincter and competency of the cardia. Am J Surg (1986) 1.64
Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg (2000) 1.63
En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma. J Thorac Cardiovasc Surg (2008) 1.61
Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg (1999) 1.60
Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg (2000) 1.59
Computerized identification of pathologic duodenogastric reflux using 24-hour gastric pH monitoring. Ann Surg (1991) 1.58
Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg (1997) 1.58
Cystic and bullous lung disease. Ann Thorac Surg (1991) 1.55
Weight gain during the first year of life in relation to maternal smoking and breast feeding in Norway. J Epidemiol Community Health (1997) 1.55
Indications, benefits and outcome of laparoscopic Nissen fundoplication. Dig Dis (1997) 1.54
CT of focal hepatic injury due to surgical retractor. AJR Am J Roentgenol (1996) 1.54
Immunosuppression in patients with Barrett's esophagus. Surgery (1992) 1.54
Potentially curable cancer of the esophagus. Cancer (1982) 1.53
Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg (2000) 1.53
The evaluation of objective measurements of gastroesophageal reflux and their contribution to patient management. Surg Clin North Am (1976) 1.52
Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg (1992) 1.50
Dysplasia in Barrett's esophagus: diagnosis, surveillance and treatment. Dig Dis (1996) 1.49
Tumors and serum glycoproteins. The 'symbodies'. Prog Exp Tumor Res (1969) 1.49
Talc pleurodesis: talc slurry versus thoracoscopic talc insufflation in a porcine model. Ann Thorac Surg (1996) 1.49
Diagnosis and management of synchronous lung cancers. J Thorac Cardiovasc Surg (1985) 1.48
Twenty-four-hour gastric luminal pH in normal subjects: influence of probe position, food, posture, and duodenogastric reflux. Am J Gastroenterol (1994) 1.48
Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann Surg (2001) 1.48
Definition of histopathologic changes in gastroesophageal reflux disease. Am J Surg Pathol (2000) 1.47
Contact cooperation in stimulated lymphocytes. I. Influence of cell contact on unspecifically stimulated lymphocytes. Exp Cell Res (1972) 1.46